PMID- 37895076 OWN - NLM STAT- MEDLINE DCOM- 20231030 LR - 20231030 IS - 1422-0067 (Electronic) IS - 1422-0067 (Linking) VI - 24 IP - 20 DP - 2023 Oct 20 TI - Association of HLA-A*11:01, -A*24:02, and -B*18:01 with Prostate Cancer Risk: A Case-Control Study. LID - 10.3390/ijms242015398 [doi] LID - 15398 AB - The major histocompatibility complex (MHC) loci, the most polymorphic regions within the human genome, encode protein complexes responsible for antigen presentation and CD4+ and CD8+ cell activation. In prostate cancer (PCa), the second most diagnosed cancer in the male population, MHC loci undergo significant changes in their expression patterns, which affect the ability of the immune system to attack and eliminate malignant cells. The purpose of this study was to explore the genetic diversity of human leukocyte antigen (HLA)-A and HLA-B in patients with PCa and healthy controls (HCs) by performing HLA genotyping using NGS technology. The analysis highlighted statistically significant differences (p < 0.05) in the prevalence of three alleles (A*11:01, A*24:02, and B*18:01). Among the HCs analyzed, 14.89% had A*11:01, 20.21% had A*24:02, and 30.61% had B*18:01; while 5.21% of patients with PCa presented A*11:01, 9.38% presented A*24:02, 18.08% presented B*18:01. Odds ratio (OR) calculations underlined a negative association between the three alleles and the risk of PCa (OR < 1). The results presented in this study suggest a protective role of A*11:01, A*24:02, and B*18:01 in PCa. FAU - Manca, Maria Antonietta AU - Manca MA AD - Dipartimento di Scienze Biomediche, Universita di Sassari, 07100 Sassari, Italy. FAU - Simula, Elena Rita AU - Simula ER AUID- ORCID: 0000-0002-8946-2679 AD - Dipartimento di Scienze Biomediche, Universita di Sassari, 07100 Sassari, Italy. FAU - Cossu, Davide AU - Cossu D AUID- ORCID: 0000-0002-0557-9467 AD - Dipartimento di Scienze Biomediche, Universita di Sassari, 07100 Sassari, Italy. FAU - Solinas, Tatiana AU - Solinas T AD - Dipartimento di Medicina, Chirurgia e Farmacia, Universita di Sassari, 07100 Sassari, Italy. AD - Struttura Complessa di Urologia, Azienda Ospedaliera Universitaria, 07100 Sassari, Italy. FAU - Madonia, Massimo AU - Madonia M AD - Dipartimento di Medicina, Chirurgia e Farmacia, Universita di Sassari, 07100 Sassari, Italy. AD - Struttura Complessa di Urologia, Azienda Ospedaliera Universitaria, 07100 Sassari, Italy. FAU - Cusano, Roberto AU - Cusano R AD - CRS4, Pula, 09100 Cagliari, Italy. FAU - Sechi, Leonardo Antonio AU - Sechi LA AUID- ORCID: 0000-0003-0566-2049 AD - Dipartimento di Scienze Biomediche, Universita di Sassari, 07100 Sassari, Italy. AD - Struttura Complessa di Microbiologia e Virologia, Azienda Ospedaliera Universitaria, 07100 Sassari, Italy. LA - eng GR - n: 2022BP837R to LAS/MUR, PRIN 2022/ GR - legge regionale 12 22 Dicembre 2022 n. 22 to LAS/Regione Autonoma della Sardegna/ PT - Journal Article DEP - 20231020 PL - Switzerland TA - Int J Mol Sci JT - International journal of molecular sciences JID - 101092791 RN - 0 (HLA-A Antigens) RN - 0 (HLA-B Antigens) RN - 0 (Histocompatibility Antigens) SB - IM MH - Humans MH - Male MH - Case-Control Studies MH - *HLA-A Antigens MH - HLA-B Antigens MH - Major Histocompatibility Complex MH - Histocompatibility Antigens MH - Alleles MH - Haplotypes MH - *Neoplasms/genetics PMC - PMC10607162 OTO - NOTNLM OT - HLA-A*11:01 OT - HLA-A*24:02 OT - HLA-B*18:01 OT - prostate cancer COIS- The authors declared no conflict of interest. EDAT- 2023/10/28 11:42 MHDA- 2023/10/30 06:47 PMCR- 2023/10/20 CRDT- 2023/10/28 01:19 PHST- 2023/08/29 00:00 [received] PHST- 2023/10/09 00:00 [revised] PHST- 2023/10/17 00:00 [accepted] PHST- 2023/10/30 06:47 [medline] PHST- 2023/10/28 11:42 [pubmed] PHST- 2023/10/28 01:19 [entrez] PHST- 2023/10/20 00:00 [pmc-release] AID - ijms242015398 [pii] AID - ijms-24-15398 [pii] AID - 10.3390/ijms242015398 [doi] PST - epublish SO - Int J Mol Sci. 2023 Oct 20;24(20):15398. doi: 10.3390/ijms242015398.